Financial specialist Owen Blicksilver PR represents Envision Pharmaceutical Services, which today announced its $2B acquisition by Rite Aid.
The move bolsters the position of the nation's No. 3 drug store chain in the fast-growing pharmaceuticals market.
Rite Aid CEO Jeff Standley said the acquisition of Envison's drugs-by-mail capability with his company's more than 4,500 retail outlets is a "compelling pharmaceutical offering."
Envision is projected to have $5B in revenues this year. Rite Aid 2014 revenues topped the $25B mark.
Private investment firm TPG, which has $65B assets under management, owns Envision.
Blicksilver's Lisa Baker and Jennifer Hurson handle Envision/TPG.
Susan Henderson is chief communications officer of Rite Aid.
No comments have been submitted for this story yet.